Virchows Archiv A

, Volume 412, Issue 4, pp 347–355 | Cite as

Axillary lymph node morphology in women with in situ breast carcinoma

An autopsy study
  • Maja Nielsen
  • Lise Christensen
  • Jorn Jensen
  • Jøorgen L. Thomsen
  • Johan A. Andersen
Article

Summary

Axillary lymph nodes in 184 female autopsy cases were studied using morphological criteria. Special attention was paid to the morphology in 34 women with in situ breast carcinoma (in situ BC) compared to the remaining women without malignant breast lesions, who served as controls. Sinus histiocytosis (SH) and diffuse cortical hyperplasia (DCH) were significantly more frequent among women with in situ BC compared to controls. No significant association was found between unilateral in situ BC and these lymph node patterns on the contralateral side. Germinal center and follicular hyperplasia (GCH/FH), lymphocyte depletion (LD), fibrosis, hyalinization, calcifications and lipomatosis were not associated with in situ BC. The results indicate that in situ BC provokes reactive morphological changes of the regional axillary lymph nodes similar to the changes associated with a good prognosis in women with invasive breast cancer (IBC).

Key words

In situ breast carcinoma Axillary lymph nodes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adler A, Stein JA, Ben-Efraim S (1980) Immunocompetence, immunosuppression, and human breast cancer. II Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T). Cancer 45:2061–2073Google Scholar
  2. Andersen JA, Nielsen M, Jensen J (1985) Essential histological findings in the female breast at autopsy. In: Zander J, Baltzer J (eds) Early breast cancer. Springer, Berlin Heidelberg New York Tokyo, pp 52–63Google Scholar
  3. Azzopardi JG (1979) Problems in breast pathology, vol II, W B Saunders, London Philadelphia Toronto, pp 113–192Google Scholar
  4. Barna BP, Deodhar SD (1978) Immunology, tumor markers, and breast cancer. Surg Clin North Am 58:693–704Google Scholar
  5. Berg JW (1956) Sinus histocytosis: A fallacious measure of host resistance to cancer. Cancer 9:935–939Google Scholar
  6. Betsill WL, Rosen PP, Lieberman PH, Robbins GF (1978) Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 239:1863–1867Google Scholar
  7. Black MM (1973) Human breast cancer, a model for cancer immunology. Isr J Med Sci 9:284–299Google Scholar
  8. Black MM, Chabon AB (1969) In situ carcinoma of the breast. Pathol Annual 4:185–210Google Scholar
  9. Black MM, Speer F (1960) Lymph node reactivity in cancer patients. Surg Gynec Obstet 110:477–487Google Scholar
  10. Cady B (1973) Total mastectomy and partial axillary dissection. Surg Clin North Am 53:313–318Google Scholar
  11. Denz FA (1947) Age changes in lymph nodes. J Pathol Bact 59:575–591Google Scholar
  12. Fisher B, Saffer EA, Fisher ER (1974) Studies concerning the regional lymph node in cancer. VII. Thymidine uptake by cells from nodes of breast cancer patients relative to axillary location and histopathologic discriminants. Cancer 33:271–279Google Scholar
  13. Fisher ER (1986) Prognostic and therapeutic significance of pathological features of breast cancer. NCI Monogr 1:29–34Google Scholar
  14. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC, and Cooperating Investigators (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol no 4). Cancer 36:1–85Google Scholar
  15. Fisher ER, Gregorio RM, Redmong C, Dekker A, Fisher B (1976) Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer. Am J Clin Pathol 65:21–30Google Scholar
  16. Fisher ER, Sass R, Fisher B, and Collaborating NSABP Investigators (1984) Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (Protocol no 4). X. Discriminants for tenth year treatment failure. Cancer 53:712–723Google Scholar
  17. Fisher ER, Saaa R, Fisher B, Wickerham L, Paik SM, and Colaborating NSABP Investigators (1986) Pathologic findings from the National Surgical Adjuvant Project (Protocol 6) I. Intraductal carcinoma (DCIS). Cancer 57:197–208Google Scholar
  18. Heidenreich W, Jagla K, Schüssler J, Börner P, Dehnhard F, Kalden JR, Leibold W, Peter HH, Deicher H (1979) Immunological characterization of mononuclear cells in peripheral blood and regional lymph nodes of breast cancer patients. Cancer 43:1308–1313Google Scholar
  19. Hunter RL, Ferguson DJ, Coppleson LW (1975) Survival with mammary cancer related to the interaction of germinal center hyperplasia and sinus histiocytosis in axillary and internal mammary lymph nodes. Cancer 36:528–539Google Scholar
  20. Kringsholm B, Christoffersen P (1987) Lymph node and thymus pathology in fatal drug addiction. Forensic Sci Int 94:245–254Google Scholar
  21. Ludwig CU, Hartmann D, Landmann R, Wesp M, Rosenfelder G, Stucki D, Buser M, Obrecht JP (1985) Unaltered immunocompetence in patients with nondisseminated breast cancer at the time of diagnosis. Cancer 55:1673–1678Google Scholar
  22. Mandeville R, Lamoureux G, Legault-Poisson S, Poisson R (1982) Biologic markers and breast cancer. A multiparametric study. II: Depressed immune competance. Cancer 50:1280–1288Google Scholar
  23. Nakajima Y, Akimoto M, Kimura M, Matano S, Hirakawa H, Kasai M (1986a) Interferon production in lymph nodes draining breast carcinoma and its augmentation by OK-432. Gan To Kagaku Ryoho 13:2766–2786Google Scholar
  24. Nakajima Y, Akimoto M, Kimura M, Sawano A, Iwasaki H, Abe R, Kasai M (1986b) Modified radical mastectomy and lymphocyte subsets of regional lymph nodes. Gan To Kagaku Ryoho 13:2182–2186Google Scholar
  25. Nielsen M, Jensen J, Andersen J (1984) Precancerous and cancerous breast lesions during lifetime and at autopsy. Cancer 54:612–615Google Scholar
  26. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle-aged women. A study of 110 medicolegal autopsies. Br J Cancer (in press)Google Scholar
  27. Page DL, Dupont WD, Rogers LW, Landenberger M (1982) intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49:751–758Google Scholar
  28. Schiøodt T (1966) Breast carcinoma. A histologic and prognostic study of 650 followed-up cases. Munksgaard, Copenhagen, pp 158–165Google Scholar
  29. Siegel H, Helpern M, Ehrenreich T (1966) The diagnosis of death from intravenous narcotism. J Forensic Sci 11:1–16Google Scholar
  30. Silverberg SG, Chitale AR, Hind AD, Frazier AB, Levitt SH (1970) Sinus histiocytosis and mammary carcinoma. Study of 366 radical mastectomies and an histological review. Cancer 26:1177–1185Google Scholar
  31. Sobin LH (1981) Histological Typing of Breast Tumours, ed. 2 Geneva, WHOGoogle Scholar
  32. Syrjänen KL (1979) Paracortical activity in the lymph nodes draining female breast carcinoma. Neoplasma 26:95–102Google Scholar
  33. Toccanier MF, Kapanci Y (1985) Lymphadenopathy in drug addicts. A study of the distribution of T-lymphocyte subsets in the lymph nodes. Virchows Arch A (Pathol Anat) 406:149–163Google Scholar
  34. Tsakraklides V, Olson P, Kersey JH, Good RA (1974) Prognostic significance of the regional lymph node histology in cancer of the breast. Cancer 34:1259–1267Google Scholar
  35. Tsakraklides V, Tsakraklides E, Good RA (1975) An autopsy study of human axillary lymph node histology. Am J Pathol 78:7–21Google Scholar
  36. Wartman WB (1959) Sinus cell hyperplasia of lymph nodes regional to adenocarcinoma of the breast and colon. Br J Cancer 13:389–397Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Maja Nielsen
    • 1
  • Lise Christensen
    • 2
  • Jorn Jensen
    • 3
  • Jøorgen L. Thomsen
    • 4
  • Johan A. Andersen
    • 5
  1. 1.Department of PathologyFrederiksberg HospitalFrederiksberg, CopenhagenDenmark
  2. 2.Department of Pathology, RigshospitaletUniversity of CopenhagenDenmark
  3. 3.Institute of PathologyEsbjerg Central HospitalEsbjergDenmark
  4. 4.University Institute of Forensic MedicineCopenhagenDenmark
  5. 5.Department of PathologyOdense University HospitalOdenseDenmark

Personalised recommendations